This pathology video presents a case study of a malignant soft tissue mass from a 25-year-old patient's arm, initially resembling a synovial sarcoma due to its cellular, fascicular, and herringbone growth pattern. The final diagnosis, based on key distinguishing microscopic features, is Malignant Peripheral Nerve Sheath Tumor (MPNST). The discussion focuses on the classic features of MPNST, including subtle pleomorphism, the characteristic "marbling" pattern (alternating cellular fascicles with loose myxoid areas), geographic necrosis, and the diagnostic clue of perivascular epithelioid clustering. Crucially, the video emphasizes the historical and practical definition of MPNST, requiring association with a nerve, neurofibroma, or Neurofibromatosis Type 1 (NF1). The utility of the H3K27me3 loss of expression as a diagnostic immunohistochemical marker and the common pitfall of expecting positive S100/SOX10 staining are also detailed.
Malignant Peripheral Nerve Sheath Tumor (MPNST) Case Review
0:08 Initial Assessment: The mass from a 25-year-old patient's arm exhibited features (spindle cells, herringbone pattern) resembling synovial sarcoma.
0:31 Distinguishing Feature: The presence of subtle pleomorphism helped distinguish the tumor from the typically uniform appearance of synovial sarcoma.
0:52 Final Diagnosis: Malignant Peripheral Nerve Sheath Tumor (MPNST).
1:10 Classic MPNST Feature (Marbling/Swirling): MPNST is characterized by the swirling or marbling together of highly cellular fascicular areas and loose, less cellular myxoid areas.
1:27 Common Findings: Additional common features include extensive geographic necrosis, where large zones of dead tissue surround islands of viable tumor.
2:00 Perivascular Clue (Dr. Weiss’s Trick): A highly useful finding in MPNST is the presence of enlarged, epithelioid tumor cells clustered around dilated vascular spaces (perivascular clustering).
3:49 Historical Diagnostic Criteria: MPNST diagnosis relies on combining morphological features with one of three criteria: 1) the sarcoma arises definitively from a nerve, 2) it grows out of a background neurofibroma (usually plexiform), or 3) it arises in a patient with known Neurofibromatosis Type 1 (NF1).
4:29 Useful IHC Marker: The histone methylating protein H3K27me3 is often lost (negative staining) in the majority of MPNSTs, particularly those not associated with NF1, making it a helpful diagnostic tool.
5:20 Takeaway on NF1: The case patient had NF1, and the tumor was found to be growing out of a plexiform neurofibroma. The video stresses the severity of NF1, citing the risk of developing this aggressive, high-grade sarcoma.
6:39 Malignant Triton Tumor Variant: Areas showing large, pink, epithelioid cells suggestive of rhabdomyoblastic differentiation are called Malignant Triton Tumor; this variant does not typically affect prognosis or treatment but is an important pathological curiosity.
8:27 IHC Pitfall (S100/SOX10): A common misconception is that MPNSTs are strongly positive for S100 or SOX10. In reality, they are usually negative or only show weak/patchy staining. Strong, diffuse staining should always prompt exclusion of melanoma, especially in superficial/skin-based tumors, as MPNST rarely occurs in the skin.